U.S. flag

An official website of the United States government

NM_001003722.2(GLE1):c.2051T>C (p.Ile684Thr) AND Lethal arthrogryposis-anterior horn cell disease syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 1, 2008
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000006836.5

Allele description [Variation Report for NM_001003722.2(GLE1):c.2051T>C (p.Ile684Thr)]

NM_001003722.2(GLE1):c.2051T>C (p.Ile684Thr)

Genes:
GLE1:GLE1 RNA export mediator [Gene - OMIM - HGNC]
LOC101929270:uncharacterized LOC101929270 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.11
Genomic location:
Preferred name:
NM_001003722.2(GLE1):c.2051T>C (p.Ile684Thr)
HGVS:
  • NC_000009.12:g.128541124T>C
  • NG_012073.1:g.41433T>C
  • NM_001003722.2:c.2051T>CMANE SELECT
  • NP_001003722.1:p.Ile684Thr
  • LRG_484:g.41433T>C
  • NC_000009.11:g.131303403T>C
  • Q53GS7:p.Ile684Thr
Protein change:
I684T; ILE684THR
Links:
UniProtKB: Q53GS7#VAR_043877; OMIM: 603371.0004; dbSNP: rs121434409
NCBI 1000 Genomes Browser:
rs121434409
Molecular consequence:
  • NM_001003722.2:c.2051T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Lethal arthrogryposis-anterior horn cell disease syndrome (CAAHD)
Synonyms:
Lethal arthrogryposis with anterior horn cell disease; CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE
Identifiers:
MONDO: MONDO:0012750; MedGen: C5193016; OMIM: 611890

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000027032OMIM
no assertion criteria provided
Pathogenic
(Feb 1, 2008)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease.

Nousiainen HO, Kestilä M, Pakkasjärvi N, Honkala H, Kuure S, Tallila J, Vuopala K, Ignatius J, Herva R, Peltonen L.

Nat Genet. 2008 Feb;40(2):155-7. doi: 10.1038/ng.2007.65. Epub 2008 Jan 20.

PubMed [citation]
PMID:
18204449
PMCID:
PMC2684619

A homozygous I684T in GLE1 as a novel cause of arthrogryposis and motor neuron loss.

Paakkola T, Vuopala K, Kokkonen H, Ignatius J, Valkama M, Moilanen JS, Fahiminiya S, Majewski J, Hinttala R, Uusimaa J.

Clin Genet. 2018 Jan;93(1):173-177. doi: 10.1111/cge.13086. Epub 2017 Nov 24.

PubMed [citation]
PMID:
28657126

Details of each submission

From OMIM, SCV000027032.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

Nousiainen et al. (2008) found that 6 of 12 Finnish patients with congenital arthrogryposis with anterior horn cell disease (CAAHD; 611890) were compound heterozygous for the Fin(Major) mutation in GLE1 (603371.0001) and a 2051T-C transition in exon 16 that changed ile684 to thr (I684T). Nousiainen et al. (2008) also found compound heterozygosity for these mutations in a patient with prolonged survival after birth who had initially been diagnosed with severe infantile spinal muscular atrophy (see 253300) but lacked SMN gene deletion.

In 2 sibs, born of consanguineous parents from northeastern Finland, with CAAHD, Paakkola et al. (2018) identified a homozygous c.2051T-C transition (c.2051T-C, NM_001003722) in the GLE1 gene, resulting in an I684T substitution in the C-terminal region that is important for nuclear localization. The mutation, which was found by a combination of homozygosity mapping and exome sequencing, segregated with the disorder in the family. The variant was found in heterozygous state in 2 of 615 Finnish individuals (frequency of 0.00163). It was also found in the ExAC database, with a slightly higher frequency among Finns (0.0006048) compared to the overall frequency (3.3 x 10(-5)). Patient fibroblasts showed decreased nuclear levels of GLE1 protein compared to controls.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 14, 2023